阿奇霉素联合匹多莫德治疗小儿支原体肺炎的效果及不良反应评价

Analysis of the effect of azithromycin combined with pidomode in the treatment of mycoplasma pneumonia in children

目的:评价阿奇霉素联合匹多莫德治疗小儿支原体肺炎的效果及不良反应发生率。方法:2018-2019年收治小儿支原体肺炎患者60例,随机分为两组,各30例。观察组采用阿奇霉素联合匹多莫德治疗,对照组采用常规治疗。比较两组临床疗效。结果:观察组不良反应发生率低于对照组,总有效率优于对照组,住院时间及退热时间短于对照组,差异均有统计学意义(P<0.05)。结论:采用阿奇霉素联合匹多莫德治疗小儿支原体肺炎患者不仅有较高的临床疗效,还能降低不良反应。

Objective:To evaluate the efficacy of azithromycin combined with pidomode in the treatment of mycoplasma pneumoniae in children.Methods:60 patients with mycoplasma pneumonia were selected from 2018 to 2019,they were randomly divided into the two groups with 30 cases in each group.The observation group was treated with azithromycin and pidomold,The control group was treated with routine therapy.The indexes of the two groups were compared.Results:The incidence of adverse reaction in the observation group was lower than the control group,the total effective rate was better than the control group,the hospitalization time and antipyretic time in the observation group were shorter than those in the control,the differences were statistically significant(P<0.05).Conclusion:Azithromycin combined with pidomode not only has a higher total effective rate,but also can reduce the adverse reactions.